| ●Publication of 2011 | ||
| next>> | ||
| 1. Terahara K, Nochi T, Yoshida M, Takahashi Y, Goto Y, Hatai H, Kurokawa S, Jang MH, Kweon MN, Domino SE, Hiroi T, Yuki Y, Tsunetsugu-Yokota Y, Kobayashi K and Kiyono H. 2011 Distinct fucosylation of M cells and epithelial cells by Fut1 and Fut2, respectively, in response to intestinal environmental stress. Biochem Biophys Res Commun 404(3): 822-8
2. Kunisawa J. and Kiyono H. 2011 Peaceful mutualism in the gut: revealing key commensal bacteria for the creation and maintenance of immunological homeostasis. Cell Host Microbe 9(2): 83-4 3. Goto Y. and Kiyono H. 2011 Epithelial cell microRNAs in gut immunity. Nat Immunol 12(3): 195-7 4. Kim DY, Sato A, Fukuyama S, Sagara H, Nagatake T, Kong IG, Goda K, Nochi T, Kunisawa J, Sato S, Yokota Y, Lee CH and Kiyono H. 2011 The Airway Antigen Sampling System: Respiratory M Cells as an Alternative Gateway for Inhaled Antigens. J Immunol 186(7): 4253-62 5. Ogawa M, Yoshida M, Goto Y, Nagatake T, Kiyono H, Sasakawa C. 2011 A tecpr1-dependent selective autophagy pathway targets bacterial pathogens. Cell Host Microbe 9(5): 376-89 6. Yamamoto M, Pascual DW and Kiyono H. 2011 M Cell-Targeted Mucosal Vaccine Strategies. Curr Top Microbiol Immunol Epub ahead of print 7. Burggraf M, Nakajima-Adachi H, Hachimura S, Ilchmann A, Pemberton AD, Kiyono H, Vieths S, Toda M. 2011 Oral tolerance induction does not resolve gastrointestinal inflammation in a mouse model offoodallergy. Mol Nutr Food Res. Epub ahead of print 8. Kunisawa J, Kurashima Y and Kiyono H. 2011 Gut-associated lymphoid tissues for the development of oral vaccines. Adv Drug Deliv Rev. Epub ahead of print 9. Stappenbeck T and Kiyono H. 2011 Editorial overview. Curr Opin Immunol. 23(4):445-7 10. Okada K, Yamasoba T and Kiyono H. 2011 Craniofacial mucosal immune system: importance of its unique organogenesis and function in the development of a mucosal vaccine. Adv Otorhinolaryngol. 72:31-6 11. Kim SH, Jung DI, Yang IY, Kim J, Lee KY, Nochi T, Kiyono H, Jang YS. 2011 M cells expressing the complement C5a receptor are efficient targets for mucosal vaccine delivery. Eur J Immunol. Epub ahead of print 12. Takeyama N, Yuki Y, and Kiyono H. 2011 Current progress in the development of mucosal vaccines. Nihon Rinsho 69(9):1555-60 13. | ||
| next>> |